Crescent Biopharma, Inc.CBIONASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Accelerating
Trending higher, above historical average, strong compound growth.
Left:
||||
Year-over-year research & development expense growth
Latest
179.68%
↑ 719% above average
Average (9y)
21.95%
Historical baseline
Range
High:179.68%
Low:-40.22%
CAGR
+22.9%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | 179.68% |
| 2023 | -29.30% |
| 2022 | -40.22% |
| 2021 | 5.70% |
| 2020 | -4.46% |
| 2019 | 17.30% |
| 2018 | 66.36% |
| 2017 | 3.51% |
| 2016 | -7.06% |
| 2015 | 28.00% |